0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection
RxNorm concept 1607803, clinical drug (scd). Prescribable name: DTaP-mIPV (generic for Quadracel) 0.5 ML Injection.
- RxCUI
- 1607803
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1607803 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
- poliovirus vaccine inactivated, type 1 (Mahoney) 763096
- poliovirus vaccine inactivated, type 2 (MEF-1) 763098
- poliovirus vaccine inactivated, type 3 (Saukett) 763100
- acellular pertussis vaccine, inactivated 798302
- diphtheria toxoid vaccine, inactivated 798304
- tetanus toxoid vaccine, inactivated 798306
Other names
diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (mIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Injection
Related concepts
- poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML (SCDC, consists of)
- poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML (SCDC, consists of)
- poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML (SCDC, consists of)
- tetanus toxoid vaccine, inactivated 10 UNT/ML (SCDC, consists of)
- diphtheria toxoid vaccine, inactivated 30 UNT/ML (SCDC, consists of)
- Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML (SCDC, consists of)
- Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML (SCDC, consists of)
- Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML (SCDC, consists of)
- Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1607803 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1607803 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1607803. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.